Jijie GuBS, MS, PhD
Dr. Jijie Gu received his Ph.D. in Biochemistry and Molecular Biology from Chinese Academy of Medical Sciences. He had his post-doctoral training in Tumor Immunology and Cancer Biology at Harvard University. He joined Abbott Laboratories and later AbbVie in 2002. Currently he is a Director, Head of Target Validation and Lead Discovery, Immunology Research at AbbVie Cambridge Research Center. Dr. Gu has more than 17 years of industry experience in target discovery and drug discovery, with expertise in therapeutic antibody generation, protein engineering, and biologics discovery, preclinical and early clinical development. Jijie contributed broadly to various antibody technology platforms and drug development pipeline in Immunology, Oncology and a few other therapeutic areas at Abbvie. As a project leader or a function head, he has initiated and delivered several drug development candidates into clinical development. Prior to his current role in target discovery, Jijie is a research fellow, head of Oncology Biologics at AbbVie Global Biologics for many years. He authored many peer reviewed articles and is an inventor for several issued and filed US and international patents. He is also on the editorial board of mAbs journal.